{"pmid":32302449,"title":"Covid-19: Countermeasure for N95 mask-induced pressure sore.","text":["Covid-19: Countermeasure for N95 mask-induced pressure sore.","As known to all, World Health Organization has declared on March 11th, 2020 that Coronavirus (Covid-19) epidemic could be characterized as a pandemic, which proposed a big challenge for healthcare works worldwide, especially doctors and nurses. The strong infectiousness of SARS-CoV-2 forces medical personnel to do good and needful safeguard against virus.","J Eur Acad Dermatol Venereol","Yin, ZhiQiang","32302449"],"abstract":["As known to all, World Health Organization has declared on March 11th, 2020 that Coronavirus (Covid-19) epidemic could be characterized as a pandemic, which proposed a big challenge for healthcare works worldwide, especially doctors and nurses. The strong infectiousness of SARS-CoV-2 forces medical personnel to do good and needful safeguard against virus."],"journal":"J Eur Acad Dermatol Venereol","authors":["Yin, ZhiQiang"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302449","week":"202016|Apr 13 - Apr 19","doi":"10.1111/jdv.16490","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664357978508099584,"score":8.233237,"similar":[{"pmid":32223003,"title":"European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis.","text":["European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis.","Atopic dermatitis (AD) is a complex disease with elevated risk of respiratory comorbidities.(1,2) Severely affected patients are often treated with immune-modulating systemic drugs.(3,4) On March 11th 2020, the World Health Organization declared the 2019 novel coronavirus severe acute respiratory syndrome (SARS-Cov-2) epidemic to be a pandemic. The number of cases worldwide is increasing exponentially and poses a major health threat, especially for those who are elderly, immuno-compromised, or have comorbidities. This also applies to AD patients on systemic immune-modulating treatment. In these days of uncertainty, reallocation of medical resources, curfew, hoarding, and shutdown of normal social life, patients, caregivers and doctors ask questions regarding the continuation of systemic immune-modulating treatment of AD patients. The ETFAD decided to address some of these questions here.","J Eur Acad Dermatol Venereol","Wollenberg, Andreas","Flohr, Carsten","Simon, Dagmar","Cork, Michael J","Thyssen, Jacob P","Bieber, Thomas","de Bruin-Weller, Marjolein S","Weidinger, Stephan","Deleuran, Mette","Taieb, Alain","Paul, Carle","Trzeciak, Magdalena","Werfel, Thomas","Seneschal, Julien","Barbarot, Sebastien","Darsow, Ulf","Torrelo, Antonio","Stalder, Jean-Francois","Svensson, Ake","Hijnen, Dirkjan","Gelmetti, Carlo","Szalai, Zsuzsanna","Gieler, Uwe","De Raeve, Linda","Kunz, Barbara","Spuls, Phyllis","von Kobyletzki, Laura B","Folster-Holst, Regina","Chernyshov, Pavel V","Cristen-Zaech, Stephanie","Heratizadeh, Annice","Ring, Johannes","Vestergaard, Christian","32223003"],"abstract":["Atopic dermatitis (AD) is a complex disease with elevated risk of respiratory comorbidities.(1,2) Severely affected patients are often treated with immune-modulating systemic drugs.(3,4) On March 11th 2020, the World Health Organization declared the 2019 novel coronavirus severe acute respiratory syndrome (SARS-Cov-2) epidemic to be a pandemic. The number of cases worldwide is increasing exponentially and poses a major health threat, especially for those who are elderly, immuno-compromised, or have comorbidities. This also applies to AD patients on systemic immune-modulating treatment. In these days of uncertainty, reallocation of medical resources, curfew, hoarding, and shutdown of normal social life, patients, caregivers and doctors ask questions regarding the continuation of systemic immune-modulating treatment of AD patients. The ETFAD decided to address some of these questions here."],"journal":"J Eur Acad Dermatol Venereol","authors":["Wollenberg, Andreas","Flohr, Carsten","Simon, Dagmar","Cork, Michael J","Thyssen, Jacob P","Bieber, Thomas","de Bruin-Weller, Marjolein S","Weidinger, Stephan","Deleuran, Mette","Taieb, Alain","Paul, Carle","Trzeciak, Magdalena","Werfel, Thomas","Seneschal, Julien","Barbarot, Sebastien","Darsow, Ulf","Torrelo, Antonio","Stalder, Jean-Francois","Svensson, Ake","Hijnen, Dirkjan","Gelmetti, Carlo","Szalai, Zsuzsanna","Gieler, Uwe","De Raeve, Linda","Kunz, Barbara","Spuls, Phyllis","von Kobyletzki, Laura B","Folster-Holst, Regina","Chernyshov, Pavel V","Cristen-Zaech, Stephanie","Heratizadeh, Annice","Ring, Johannes","Vestergaard, Christian"],"date":"2020-03-31T11:00:00Z","year":2020,"_id":"32223003","week":"202014|Mar 30 - Apr 05","doi":"10.1111/jdv.16411","keywords":["COVID-19","SARS-CoV-2","atopic dermatitis","immunosuppressant","systemic therapy"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663352135212859394,"score":126.79024},{"pmid":32235433,"title":"Corona Virus (COVID-19) \"Infodemic\" and Emerging Issues through a Data Lens: The Case of China.","text":["Corona Virus (COVID-19) \"Infodemic\" and Emerging Issues through a Data Lens: The Case of China.","Coronavirus (COVID-19) is a humanitarian emergency, which started in Wuhan in China in early December 2019, brought into the notice of the authorities in late December, early January 2020, and, after investigation, was declared as an emergency in the third week of January 2020. The WHO declared this as Public Health Emergency of International Concern (PHEIC) on 31th of January 2020, and finally a pandemic on 11th March 2020. As of March 24th, 2020, the virus has caused a casualty of over 16,600 people worldwide with more than 380,000 people confirmed as infected by it, of which more than 10,000 cases are serious. Mainly based on Chinese newspapers, social media and other digital platform data, this paper analyzes the timeline of the key actions taken by the government and people over three months in five different phases. It found that although there was an initial delay in responding, a unique combination of strong governance, strict regulation, strong community vigilance and citizen participation, and wise use of big data and digital technologies, were some of the key factors in China's efforts to combat this virus. Being inviable and non-measurable (unlike radioactive exposure), appropriate and timely information is very important to form the basic foundation of mitigation and curative measures. Infodemic, as it is termed by WHO, is a key word, where different stakeholder's participation, along with stricter regulation, is required to reduce the impact of fake news in this information age and social media. Although different countries will need different approaches, focusing on its humanitarian nature and addressing infodemic issues are the two critical factors for future global mitigation efforts.","Int J Environ Res Public Health","Hua, Jinling","Shaw, Rajib","32235433"],"abstract":["Coronavirus (COVID-19) is a humanitarian emergency, which started in Wuhan in China in early December 2019, brought into the notice of the authorities in late December, early January 2020, and, after investigation, was declared as an emergency in the third week of January 2020. The WHO declared this as Public Health Emergency of International Concern (PHEIC) on 31th of January 2020, and finally a pandemic on 11th March 2020. As of March 24th, 2020, the virus has caused a casualty of over 16,600 people worldwide with more than 380,000 people confirmed as infected by it, of which more than 10,000 cases are serious. Mainly based on Chinese newspapers, social media and other digital platform data, this paper analyzes the timeline of the key actions taken by the government and people over three months in five different phases. It found that although there was an initial delay in responding, a unique combination of strong governance, strict regulation, strong community vigilance and citizen participation, and wise use of big data and digital technologies, were some of the key factors in China's efforts to combat this virus. Being inviable and non-measurable (unlike radioactive exposure), appropriate and timely information is very important to form the basic foundation of mitigation and curative measures. Infodemic, as it is termed by WHO, is a key word, where different stakeholder's participation, along with stricter regulation, is required to reduce the impact of fake news in this information age and social media. Although different countries will need different approaches, focusing on its humanitarian nature and addressing infodemic issues are the two critical factors for future global mitigation efforts."],"journal":"Int J Environ Res Public Health","authors":["Hua, Jinling","Shaw, Rajib"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32235433","week":"202014|Mar 30 - Apr 05","doi":"10.3390/ijerph17072309","keywords":["*COVID-19","*Coronavirus","*citizen participation","*data science","*good governance","*humanitarian emergency","*infodemic"],"source":"PubMed","locations":["Chinese","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352135614464002,"score":116.89738},{"pmid":32279694,"title":"Concise Communication: Covid-19 and the N95 Respirator Shortage: Closing the Gap.","text":["Concise Communication: Covid-19 and the N95 Respirator Shortage: Closing the Gap.","Due to extreme shortages of personal protective equipment caused by the COVID-19 pandemic, many healthcare workers will be forced to recycle protective masks intended for disposal after a single use. We propose investigating the use of ultraviolet germicidal irradiation to sterilize masks of SARS-CoV-2 for safer re-use.","Infect Control Hosp Epidemiol","Nogee, Daniel","Tomassoni, Anthony","32279694"],"abstract":["Due to extreme shortages of personal protective equipment caused by the COVID-19 pandemic, many healthcare workers will be forced to recycle protective masks intended for disposal after a single use. We propose investigating the use of ultraviolet germicidal irradiation to sterilize masks of SARS-CoV-2 for safer re-use."],"journal":"Infect Control Hosp Epidemiol","authors":["Nogee, Daniel","Tomassoni, Anthony"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32279694","week":"202016|Apr 13 - Apr 19","doi":"10.1017/ice.2020.124","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664182200720949249,"score":102.36177},{"pmid":32271599,"title":"COVID19 Prevention & Care; A Cancer Specific Guideline.","text":["COVID19 Prevention & Care; A Cancer Specific Guideline.","On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: first, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses.","Arch Iran Med","Motlagh, Ali","Yamrali, Maisa","Azghandi, Samira","Azadeh, Payam","Vaezi, Mohammad","Ashrafi, Farzaneh","Zendehdel, Kazem","Mirzaei, Hamidreza","Basi, Ali","Rakhsha, Afshin","Seifi, Sharareh","Tabatabaeefar, Morteza","Elahi, Ahmad","Pirjani, Pouneh","Moadab Shoar, Leila","Nadarkhani, Faranak","Khoshabi, Mostafa","Bahar, Massih","Esfahani, Fatemeh","Fudazi, Hossein","Samiei, Farhad","Farazmand, Borna","Ahmari, Azin","Vand Rajabpour, Mojtaba","Janbabaei, Ghasem","Raisi, Alireza","Ostovar, Afshin","Malekzadeh, Reza","32271599"],"abstract":["On March 11th 2020, the coronavirus outbreak was declared a pandemic by the WHO. One of the groups that is considered high risk in this pandemic are cancer patients as they are treated with a variety of immune system suppressor treatment modalities and this puts them in a great risk for infectious disease (including COVID-19). Therefore, cancer patients require higher level measures for preventing and treating infectious diseases. furthermore, cancer patients may bear additional risk due to the restriction of access to the routine diagnostic and therapeutic services during such epidemic. Since most of the attention of health systems is towards patients affected with COVID-19, the need for structured and unified approaches to COVID-19 prevention and care specific to cancer patients and cancer centers is felt more than ever. This article provides the recommendations and possible actions that should be considered by patients, their caregivers and families, physician, nurses, managers and staff of medical centers involved in cancer diagnosis and treatment. We pursued two major goals in our recommendations: first, limiting the exposure of cancer patients to medical environments and second, modifying the treatment modalities in a manner that reduces the probability of myelosuppression such as delaying elective diagnostic and therapeutic services, shortening the treatment course, or prolonging the interval between treatment courses."],"journal":"Arch Iran Med","authors":["Motlagh, Ali","Yamrali, Maisa","Azghandi, Samira","Azadeh, Payam","Vaezi, Mohammad","Ashrafi, Farzaneh","Zendehdel, Kazem","Mirzaei, Hamidreza","Basi, Ali","Rakhsha, Afshin","Seifi, Sharareh","Tabatabaeefar, Morteza","Elahi, Ahmad","Pirjani, Pouneh","Moadab Shoar, Leila","Nadarkhani, Faranak","Khoshabi, Mostafa","Bahar, Massih","Esfahani, Fatemeh","Fudazi, Hossein","Samiei, Farhad","Farazmand, Borna","Ahmari, Azin","Vand Rajabpour, Mojtaba","Janbabaei, Ghasem","Raisi, Alireza","Ostovar, Afshin","Malekzadeh, Reza"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271599","week":"202015|Apr 06 - Apr 12","doi":"10.34172/aim.2020.07","keywords":["COVID-19","Cancer","Pandemic"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663620083154419712,"score":100.33512},{"pmid":32219845,"title":"Responding to COVID-19: How to Navigate a Public Health Emergency Legally and Ethically.","text":["Responding to COVID-19: How to Navigate a Public Health Emergency Legally and Ethically.","Few novel or emerging infectious diseases have posed such vital ethical challenges so quickly and dramatically as the novel coronavirus SARS-CoV-2. The World Health Organization declared a public health emergency of international concern and recently classified COVID-19 as a worldwide pandemic. As of this writing, the epidemic has not yet peaked in the United States, but community transmission is widespread. President Trump declared a national emergency as fifty governors declared state emergencies. In the coming weeks, hospitals will become overrun, stretched to their capacities. When the health system becomes stretched beyond capacity, how can we ethically allocate scarce health goods and services? How can we ensure that marginalized populations can access the care they need? What ethical duties do we owe to vulnerable people separated from their families and communities? And how do we ethically and legally balance public health with civil liberties?","Hastings Cent Rep","Gostin, Lawrence O","Friedman, Eric A","Wetter, Sarah A","32219845"],"abstract":["Few novel or emerging infectious diseases have posed such vital ethical challenges so quickly and dramatically as the novel coronavirus SARS-CoV-2. The World Health Organization declared a public health emergency of international concern and recently classified COVID-19 as a worldwide pandemic. As of this writing, the epidemic has not yet peaked in the United States, but community transmission is widespread. President Trump declared a national emergency as fifty governors declared state emergencies. In the coming weeks, hospitals will become overrun, stretched to their capacities. When the health system becomes stretched beyond capacity, how can we ethically allocate scarce health goods and services? How can we ensure that marginalized populations can access the care they need? What ethical duties do we owe to vulnerable people separated from their families and communities? And how do we ethically and legally balance public health with civil liberties?"],"journal":"Hastings Cent Rep","authors":["Gostin, Lawrence O","Friedman, Eric A","Wetter, Sarah A"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32219845","week":"202013|Mar 23 - Mar 29","doi":"10.1002/hast.1090","keywords":["COVID-19","allocation of scarce resources","civil liberties","crisis standards of care","novel coronavirus SARS-CoV-2","public health emergency","public health ethics"],"source":"PubMed","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1663352135067107328,"score":98.43432}]}